Portable objective assessment of upper extremity motor function in Parkinson's disease

L. M. Chahine, L. Uribe, Penelope (Penny) Hogarth, J. McNames, A. Siderowf, K. Marek, D. Jennings

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction Objective, portable measures of motor function for out-of-office assessments are needed in Parkinson's Disease (PD). This study had 3 objectives. First, to examine change in objective motor measurements in PD (as assessed with the Objective PD Measurement (OPDM) system). Second, to correlate objective measures with clinical features and putative PD cerebrospinal fluid (CSF) and dopaminergic imaging biomarkers. Third, to assess participant compliance with and perceptions of serial in-home motor assessments. Methods De novo PD subjects participating in this pilot study of the Parkinson Progression Markers Initiative (PPMI) completed OPDM assessments at home weekly for 3 months and in the clinic at baseline and 3-, 6-, and 12-months. Tasks included (i)digitography (ii)a repetitive hand tapping task and (iii)timed pegboard task. A global objective motor score (OMS) was derived from the latter three. MDS-UPDRS-III score was obtained at each time point, and CSF and dopamine transporter (DAT) SPECT at baseline. Results 27 participants, mean age 62.6 years, 19 male were included. A mean of 10.5 in-home assessments were completed. There was no significant change in in-home OMS over 12 weeks (p = 0.48). There was strong correlation between mean baseline OMS and MDS-UPDRS-III scores (spearman's rho = 0.60, p=<0.0001). Baseline OMS predicted 6-month MDS-UPDRS-III (β = 0.80, p = 0.0002) but not change in MDS-UPDRS-III score, DAT SPECT, or putative CSF biomarkers. Conclusions This study suggests that administration of in-home motor tasks as part of a large multi-center study is feasible and scores derived from these assessments may serve as surrogates of in-person clinician-assessed motor score.

Original languageEnglish (US)
Pages (from-to)61-66
Number of pages6
JournalParkinsonism and Related Disorders
Volume43
DOIs
StatePublished - Oct 1 2017

Fingerprint

Upper Extremity
Parkinson Disease
Cerebrospinal Fluid
Dopamine Plasma Membrane Transport Proteins
Single-Photon Emission-Computed Tomography
Biomarkers
Hand

Keywords

  • Objective motor testing
  • Parkinson's disease

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Cite this

Portable objective assessment of upper extremity motor function in Parkinson's disease. / Chahine, L. M.; Uribe, L.; Hogarth, Penelope (Penny); McNames, J.; Siderowf, A.; Marek, K.; Jennings, D.

In: Parkinsonism and Related Disorders, Vol. 43, 01.10.2017, p. 61-66.

Research output: Contribution to journalArticle

Chahine, L. M. ; Uribe, L. ; Hogarth, Penelope (Penny) ; McNames, J. ; Siderowf, A. ; Marek, K. ; Jennings, D. / Portable objective assessment of upper extremity motor function in Parkinson's disease. In: Parkinsonism and Related Disorders. 2017 ; Vol. 43. pp. 61-66.
@article{b7c8665288b2425981288daa2fcaa53f,
title = "Portable objective assessment of upper extremity motor function in Parkinson's disease",
abstract = "Introduction Objective, portable measures of motor function for out-of-office assessments are needed in Parkinson's Disease (PD). This study had 3 objectives. First, to examine change in objective motor measurements in PD (as assessed with the Objective PD Measurement (OPDM) system). Second, to correlate objective measures with clinical features and putative PD cerebrospinal fluid (CSF) and dopaminergic imaging biomarkers. Third, to assess participant compliance with and perceptions of serial in-home motor assessments. Methods De novo PD subjects participating in this pilot study of the Parkinson Progression Markers Initiative (PPMI) completed OPDM assessments at home weekly for 3 months and in the clinic at baseline and 3-, 6-, and 12-months. Tasks included (i)digitography (ii)a repetitive hand tapping task and (iii)timed pegboard task. A global objective motor score (OMS) was derived from the latter three. MDS-UPDRS-III score was obtained at each time point, and CSF and dopamine transporter (DAT) SPECT at baseline. Results 27 participants, mean age 62.6 years, 19 male were included. A mean of 10.5 in-home assessments were completed. There was no significant change in in-home OMS over 12 weeks (p = 0.48). There was strong correlation between mean baseline OMS and MDS-UPDRS-III scores (spearman's rho = 0.60, p=<0.0001). Baseline OMS predicted 6-month MDS-UPDRS-III (β = 0.80, p = 0.0002) but not change in MDS-UPDRS-III score, DAT SPECT, or putative CSF biomarkers. Conclusions This study suggests that administration of in-home motor tasks as part of a large multi-center study is feasible and scores derived from these assessments may serve as surrogates of in-person clinician-assessed motor score.",
keywords = "Objective motor testing, Parkinson's disease",
author = "Chahine, {L. M.} and L. Uribe and Hogarth, {Penelope (Penny)} and J. McNames and A. Siderowf and K. Marek and D. Jennings",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.parkreldis.2017.07.017",
language = "English (US)",
volume = "43",
pages = "61--66",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Portable objective assessment of upper extremity motor function in Parkinson's disease

AU - Chahine, L. M.

AU - Uribe, L.

AU - Hogarth, Penelope (Penny)

AU - McNames, J.

AU - Siderowf, A.

AU - Marek, K.

AU - Jennings, D.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Introduction Objective, portable measures of motor function for out-of-office assessments are needed in Parkinson's Disease (PD). This study had 3 objectives. First, to examine change in objective motor measurements in PD (as assessed with the Objective PD Measurement (OPDM) system). Second, to correlate objective measures with clinical features and putative PD cerebrospinal fluid (CSF) and dopaminergic imaging biomarkers. Third, to assess participant compliance with and perceptions of serial in-home motor assessments. Methods De novo PD subjects participating in this pilot study of the Parkinson Progression Markers Initiative (PPMI) completed OPDM assessments at home weekly for 3 months and in the clinic at baseline and 3-, 6-, and 12-months. Tasks included (i)digitography (ii)a repetitive hand tapping task and (iii)timed pegboard task. A global objective motor score (OMS) was derived from the latter three. MDS-UPDRS-III score was obtained at each time point, and CSF and dopamine transporter (DAT) SPECT at baseline. Results 27 participants, mean age 62.6 years, 19 male were included. A mean of 10.5 in-home assessments were completed. There was no significant change in in-home OMS over 12 weeks (p = 0.48). There was strong correlation between mean baseline OMS and MDS-UPDRS-III scores (spearman's rho = 0.60, p=<0.0001). Baseline OMS predicted 6-month MDS-UPDRS-III (β = 0.80, p = 0.0002) but not change in MDS-UPDRS-III score, DAT SPECT, or putative CSF biomarkers. Conclusions This study suggests that administration of in-home motor tasks as part of a large multi-center study is feasible and scores derived from these assessments may serve as surrogates of in-person clinician-assessed motor score.

AB - Introduction Objective, portable measures of motor function for out-of-office assessments are needed in Parkinson's Disease (PD). This study had 3 objectives. First, to examine change in objective motor measurements in PD (as assessed with the Objective PD Measurement (OPDM) system). Second, to correlate objective measures with clinical features and putative PD cerebrospinal fluid (CSF) and dopaminergic imaging biomarkers. Third, to assess participant compliance with and perceptions of serial in-home motor assessments. Methods De novo PD subjects participating in this pilot study of the Parkinson Progression Markers Initiative (PPMI) completed OPDM assessments at home weekly for 3 months and in the clinic at baseline and 3-, 6-, and 12-months. Tasks included (i)digitography (ii)a repetitive hand tapping task and (iii)timed pegboard task. A global objective motor score (OMS) was derived from the latter three. MDS-UPDRS-III score was obtained at each time point, and CSF and dopamine transporter (DAT) SPECT at baseline. Results 27 participants, mean age 62.6 years, 19 male were included. A mean of 10.5 in-home assessments were completed. There was no significant change in in-home OMS over 12 weeks (p = 0.48). There was strong correlation between mean baseline OMS and MDS-UPDRS-III scores (spearman's rho = 0.60, p=<0.0001). Baseline OMS predicted 6-month MDS-UPDRS-III (β = 0.80, p = 0.0002) but not change in MDS-UPDRS-III score, DAT SPECT, or putative CSF biomarkers. Conclusions This study suggests that administration of in-home motor tasks as part of a large multi-center study is feasible and scores derived from these assessments may serve as surrogates of in-person clinician-assessed motor score.

KW - Objective motor testing

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=85025146415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025146415&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2017.07.017

DO - 10.1016/j.parkreldis.2017.07.017

M3 - Article

C2 - 28747279

AN - SCOPUS:85025146415

VL - 43

SP - 61

EP - 66

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

ER -